Thomas A. Shea serves as Executive at EPIRUS Biopharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Thomas A. Shea has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 27, 2016 involved selling 1,554 shares valued at $4.4K.
Thomas A. Shea currently holds 31,489 shares of EPIRUS Biopharmaceuticals, Inc. (EPRS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas A. Shea has been a net neutral trader of EPRS stock. They have purchased $0 and sold $0 worth of shares.
Thomas A. Shea's most recent insider trade was on Feb 27, 2016, when they sold 1,554 shares at $2.80 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 27, 2016 | EPRS | $0 | Option Exercise | 1,044 | $N/A | Discretionary |
| Nov 3, 2015 | EPRS | $37.6K | Option Exercise | 28,926 | $1.30 | Discretionary |